12 Analysts Have This to Say About HCA Healthcare
Portfolio Pulse from Benzinga Insights
HCA Healthcare (NYSE:HCA) has received various analyst ratings over the last quarter, with 4 bullish, 6 somewhat bullish, and 2 indifferent ratings. The average 12-month price target among 12 analysts is $284.17, with a high of $315.00 and a low of $254.00. This target has decreased by 8.5% from the previous average of $310.56. Analysts provide these ratings based on research and forecasts, which are subject to change.
November 10, 2023 | 6:00 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
HCA Healthcare has a mix of bullish and somewhat bullish ratings from analysts, with an average price target of $284.17, which is down 8.5% from the previous target.
The mixed analyst ratings with a majority leaning towards bullish and somewhat bullish indicate a generally positive outlook, but the decrease in the average price target could signal a more cautious view in the short term. The impact on the stock price is likely to be neutral in the short term as the ratings are mixed and the decrease in the target price has already been communicated to the market.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100